Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis.
about
Extracellular vesicles as mediators of vascular inflammation in kidney diseasePlatelet function tests: a review of progresses in clinical applicationMethodological challenges in utilizing miRNAs as circulating biomarkersNovel methodologies for biomarker discovery in atherosclerosisExosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functionsGenetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.Emerging role of exosome-mediated intercellular communication in vascular remodelingRole of microparticles in endothelial dysfunction and arterial hypertension.Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.Microparticles from apoptotic platelets promote resident macrophage differentiation.Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device.Lectin-Based Characterization of Vascular Cell Microparticle GlycocalyxMicroparticles: major transport vehicles for distinct microRNAs in circulation.Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress.Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy.N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.Flotillin-2 Gene Is Associated with Coronary Artery Disease in Chinese Han PopulationThe significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smokingNo Significant Reduction of Circulating Endothelial-Derived and Platelet-Derived Microparticles in Patients with Psoriasis Successfully Treated with Anti-IL12/23Endothelial activation microparticles and inflammation status improve with exercise training in african americans.Serum extracellular vesicle protein levels are associated with acute coronary syndrome.Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography.Platelet CD40L at the interface of adaptive immunityExosome mimetics: a novel class of drug delivery systems.Insulin resistance, diabetes, and cardiovascular risk.Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles.Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.Coordinate stimulation of macrophages by microparticles and TLR ligands induces foam cell formationGene Expression Profiling and Functional Characterization of Macrophages in Response to Circulatory Microparticles Produced during Trypanosoma cruzi Infection and Chagas Disease.Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles.Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity.Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI).Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk.High-Dose Vitamin C Injection to Cancer Patients May Promote Thrombosis Through Procoagulant Activation of Erythrocytes.New frontiers for platelet CD154.The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
P2860
Q26765072-EFC61445-2599-4B4F-A6A7-AA30D43C7397Q26823775-9914DDB0-F206-493A-9F1A-1DA4CF0DF569Q27027950-3FF7DF5B-6FC2-4DA7-AB1C-DE3AF521D34DQ28088373-455E91BF-F480-47E0-BCBC-7E9D4C0DF29BQ30597581-637DC5B5-4133-4078-BA20-175751027B7EQ30650321-7C47C08C-1D76-47CE-AB44-9BBA5CBCAA00Q33649005-F4139579-452B-4842-A442-C4F7498B1EA0Q34574014-8F2348CE-9678-4ECA-B32B-E55A75286252Q34991385-340AE337-1E7F-4D78-B37C-3F7AD87DF7BFQ35269888-84FCA1AF-B340-48E0-B7AE-0E7B41CE14DCQ35542818-FC50921C-5CF0-439E-9936-DD4024E821FEQ35746142-6E1C0C4D-0861-4D4E-9CB7-8DC01EFE6475Q35792749-D9780E80-5356-4538-BDD8-9F35800334AFQ35816071-49446767-8A6E-4748-A859-2CFCF847ADA6Q35872535-FB26A92B-CF78-44F2-B0DE-72811D39BE87Q35949057-A184ED38-A965-4E01-9A34-D4D94DF48CD5Q36297823-D697B4E5-09A2-4471-9790-3F98457D3B11Q36367670-5E836EF5-E45F-41E9-A568-159C13A55817Q36723994-64DFB91A-942F-4FAD-A97A-692540267894Q36828238-200F6FD4-9ED9-4DF2-A875-CD6B42A69CDBQ36838268-BEEEE1CB-774F-4AFF-90A1-8B9C6417098DQ37141019-64F5BDAE-2111-4F3E-9A84-42D01FD4DB7FQ37648544-F16B76E7-939F-46EF-A309-C549ACD67B80Q37695163-CCCC66EF-78A4-4041-925F-2F9C1FE9C9E5Q37809369-8E94CFB4-C2D7-4484-AE90-D3256AB5A877Q38012446-8CE73BE6-2B4B-468C-B241-01301465B36EQ38208221-5AB27372-9A62-487A-8E98-5945BA19C594Q38777078-4CF7B3F6-53ED-4B00-AAB3-EB55B8A5824BQ38853000-903377D1-50B0-4957-B563-FABFA20F0915Q38860377-DE279D0C-29BE-464C-AC3C-95CE72F72CFBQ38908954-15983724-22B4-4D1D-AA43-BF74AF2C375BQ39270246-8B70CCB3-7AAF-475E-BDEC-A5BAE69CFAC5Q40429340-9A3678C0-CCD3-4145-A82D-60876F4CB736Q41105522-8C74C4A6-1440-42DB-9D34-B4C4DFD73082Q41700530-B3BB4913-E677-44C6-AD75-C0AD7EA2A3DBQ42293427-815CC18D-BD1B-43E4-A90E-151A7589C8D8Q42363103-1DF4BF25-A531-46CA-A06A-165148BFD34DQ42701294-19BA25DE-4330-41DF-B32C-7A09AAB899B3Q43182095-E98D7D40-4E94-4E24-A1AD-7FFF9C12FA56Q44922653-702D657E-C3E6-4621-84E2-02461171A54F
P2860
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Circulating microparticles in ...... ogenesis and atherothrombosis.
@en
Circulating microparticles in ...... ogenesis and atherothrombosis.
@nl
type
label
Circulating microparticles in ...... ogenesis and atherothrombosis.
@en
Circulating microparticles in ...... ogenesis and atherothrombosis.
@nl
prefLabel
Circulating microparticles in ...... ogenesis and atherothrombosis.
@en
Circulating microparticles in ...... ogenesis and atherothrombosis.
@nl
P1476
Circulating microparticles in ...... ogenesis and atherothrombosis.
@en
P2093
E Shantsila
P W Kamphuisen
P304
P356
10.1111/J.1538-7836.2010.04007.X
P577
2010-11-01T00:00:00Z